Guest guest Posted February 19, 2006 Report Share Posted February 19, 2006 Hello everyone, I'm new to the forum and have been watching and reading other posts for a while now. I have done a lot of research on H5N1, mostly from a western medical perspective. I would like discussion from you all from a perspective on pathogen differentiation and treatment stratigies. I have talked to a lot of other practitioners and I get the sense that no one really has a firm handle on this. Some say it's a Wind Cold, some say it's a hot pestilential evil. From what I've gathered, it starts as a WC and quickly moves to the blood level. It seems signs and symptoms often first manifest at a Yang Ming stage. I have been studying Dr.Shubiti Darmanandas site and downloaded his paper on " Chinese Medicines Response to Avian Influenza " . I found this helpful. I am most concerned with the Cytokine cascade that causes massive inflamation, internal hemmorage ARDS and respiratory failure. Onset of S & S to death, in many cases is less than a week. Recent genetic alteration in the H5N1 hemagglutinin gene have occured that would lead to more efficient transmission of H5N1 to humans. This genetic change was linked to H5N1 from migrating birds flying into the Middle East and infecting birds indigenous to the region already carrying another avian influenza sero-type, H9N2.On January 19th, the scientific journal, Nature, summarized this development and described ongoing research at the National Institute of Medical Research (NIMR), in London, that identified the genetic alteration, S227N (also called S223N)In late December 2005, the first human infections by the Qinghai strain of H5N1 were reported in Turkey. S227N was detected in the index case for that outbreak with six additional cases confirmed four of whom died. " H5N1 is migrating into areas where it is encountering unique influenza sero- types it has not encountered while largely confined to Asia over the past few years. This expanded geographical reach allows H5N1 to exchange genetic material with novel donor sequences, which under the appropriate selection pressures, enables the genetic changes to become fixed in the genome of the virus. H5N1 is in the process of acquiring genetic information that allows for more efficient infections of humans " , said Recombinomics President, Dr. Henry Niman. So how does CHM deal with this? Thanks for your time and thoughts. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.